Ultragenyx Pharmaceutical Inc. (RARE) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, ALNY, AMLX, APLS, ARVN, CRNX and others.
RARE has a market capitalization of $2.37B, compared to an average peer market cap of $6.96B. RARE is notably smaller than its average peer.
